Showing 1 - 10 results of 10 for search 'Ron A. A. Mathôt', query time: 0.09s Refine Results
  1. 1
    Adoption of Machine Learning in Pharmacometrics: An Overview of Recent Implementations and Their Considerations

    Adoption of Machine Learning in Pharmacometrics: An Overview of Recent Implementations and Their Considerations by Alexander Janssen, Frank C. Bennis, Ron A. A. Mathôt

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Application of SHAP values for inferring the optimal functional form of covariates in pharmacokinetic modeling

    Application of SHAP values for inferring the optimal functional form of covariates in pharmacokinetic modeling by Alexander Janssen, Mark Hoogendoorn, Marjon H. Cnossen, Ron A. A. Mathôt, the OPTI‐CLOT Study Group and SYMPHONY Consortium

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Transcapillary escape rate of 125I-albumin in relation to timing of blood sampling: the need for standardization

    Transcapillary escape rate of 125I-albumin in relation to timing of blood sampling: the need for standardization by Youssef Chahid, Nienke M. G. Rorije, Soufian el Boujoufi, Ron A. A. Mathôt, Liffert Vogt, Hein J. Verberne

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab

    Development and validation of an LC-MS/MS method for simultaneous quantification of co-administered trastuzumab and pertuzumab by Sandor Schokker, Fabrizia Fusetti, Francesco Bonardi, Remco J. Molenaar, Ron A.A. Mathôt, Hanneke W.M. van Laarhoven

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Deep compartment models: A deep learning approach for the reliable prediction of time‐series data in pharmacokinetic modeling

    Deep compartment models: A deep learning approach for the reliable prediction of time‐series data in pharmacokinetic modeling by Alexander Janssen, Frank W. G. Leebeek, Marjon H. Cnossen, Ron A. A. Mathôt, the OPTI‐CLOT study group and SYMPHONY consortium

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Relationship between factor VIII levels and bleeding for rFVIII‐SingleChain in severe hemophilia A: A repeated time‐to‐event analysis

    Relationship between factor VIII levels and bleeding for rFVIII‐SingleChain in severe hemophilia A: A repeated time‐to‐event analysis by Laura H. Bukkems, Siv Jönsson, Marjon H. Cnossen, Mats O. Karlsson, Ron A. A. Mathôt, the OPTI‐CLOT studies and the SYMPHONY consortium

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space

    PBPK modeling of recombinant factor IX Fc fusion protein (rFIXFc) and rFIX to characterize the binding to type 4 collagen in the extravascular space by Michael E. Cloesmeijer, Erik Sjögren, Sjoerd F. Koopman, Peter. J. Lenting, Marjon H. Cnossen, Ron A. A. Mathôt, the OPTI‐CLOT study group and SYMPHONY consortium

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Pharmacokinetic/Pharmacodynamic Target Attainment of Ceftazidime in Adult Patients on General Wards with Different Degrees of Renal Function: A Prospective Observational Bicenter Cohort Study

    Pharmacokinetic/Pharmacodynamic Target Attainment of Ceftazidime in Adult Patients on General Wards with Different Degrees of Renal Function: A Prospective Observational Bicenter C... by Saskia E. Zieck, Suzanne L. de Vroom, Frouke Ph. Mulder, Gitte van Twillert, Ron A. A. Mathôt, Suzanne E. Geerlings, Reinier M. van Hest

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected <i>Pseudomonas aeruginosa</i> Infection

    Population Pharmacokinetics and Probability of Target Attainment of Different Dosing Regimens of Ceftazidime in Critically Ill Patients with a Proven or Suspected <i>Pseudomonas ae... by Annabel Werumeus Buning, Caspar J. Hodiamont, Natalia M. Lechner, Margriet Schokkin, Paul W. G. Elbers, Nicole P. Juffermans, Ron A. A. Mathôt, Menno D. de Jong, Reinier M. van Hest

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel

    Systemic effects of angiogenesis inhibition alter pharmacokinetics and intratumoral delivery of nab-paclitaxel by Anne Steins, Eva A. Ebbing, Marcel C. M. Pistorius, Cynthia Waasdorp, Kausilia K. Krishnadath, Jan Paul Medema, Johanna W. Wilmink, Ron A. A. Mathôt, Maarten F. Bijlsma, Hanneke W. M. van Laarhoven

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: